In recent study, Yoon et al 12) found that increased aortic stiff

In recent study, Yoon et al.12) found that increased aortic stiffness is associated with advanced cerebrovascular ischemia. Although there was no information about the current medication that might affect arterial stiffness and about whether presence of target organ damage such as microalbuminuria or left ventricular hypertrophy, and

even the research was cross-sectional design, it is decisive that increased aortic stiffness represents more aggressive disease manifestation. We need Inhibitors,research,lifescience,medical MI-773 cell line future investigation about usefulness of aortic stiffness as a predictor of future ischemic stroke or as a predictor of recurrent cerebrovascular event in patients with previous TIA or stroke. Furthermore development Inhibitors,research,lifescience,medical of its cut-off value for prediction of development or recurrence of ischemic stroke might helpful for real clinical

practice.
A 72-year-old obese woman, with history of arterial hypertension 17 presented to emergency department with a 10-day history of progressive dyspnoea Inhibitors,research,lifescience,medical (NYHA class III/IV). Prior this examination, she experienced 18 days before a collapse with consequent fracture of the left humerus. She has subjected to immobilization. On physical examination, the patients was a haemodinamicaly stable, with a normal auscultatory findings, a blood pressure of 120/80 mmHg, regular pulse rate of 125 bpm, and respiratory rate of 16 breaths/min. After removing immobilization left arm swelling was revealed. The

electrocardiogram revealed sinus tachycardia Inhibitors,research,lifescience,medical with S1Q3T3 pattern. Blood gas analysis obtained on room air showed slightly decreased oxygen partial pressure (8 kPa) and saturation (90%). Echocardiography revealed highly mobile thrombus in the dilated right atrium (Fig. 1A and B), dilated and hypokinetic right ventricle, mild tricuspide regurgitation and moderate pulmonary artery hypertension (systolic pulmonary arterial pressure was 60 mmHg). A venous ultrasonography (Fig. Inhibitors,research,lifescience,medical 1C) demonstrated that thrombi were originated in the deep veins of the left arm. The intermediate-risk pulmonary embolism (PE) was diagnosed. Considering patient’s age, functional status, and patient’s consent after crotamiton the therapeutic options was explained, thrombolytic therapy (streptokinase, 1.5 MU over 2 hours) was performed. Within 20 hours after thrombolysis, echocardiography demonstrated complete dissolution of the right atrial thrombus, improved right ventricular function, and reduction of the pulmonary arterial pressure (for approximately 20 mmHg). No adverse effects of the therapy were noted. Anticoagulation therapy with LWMH low molecular weight heparin and warfarin was started, and the patient was discharged after 10 days.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>